LGI1 Autoimmune Encephalitis - Satralizumab | Clinical Trial Radar | Chugai Pharmaceutical

Powered by Trial Radar

Advanced

Trial Radar AI Trial Candidate or Patient Patient Caregiver Healthcare Pro Biotech Pro Biotech Investor Researcher Other
	Let's discuss and explore clinical trials with Chugai Pharmaceutical as a lead sponsor or collaborator. Showing clinical trials for LGI1 Autoimmune Encephalitis. I can help you find nearby clinical trials and understand health conditions and treatments.

Search by location, facility...

Search by keywords...

Study Title	Status
A Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Satralizumab in Participants With Anti-N-methyl-D-aspartic Acid Receptor (NMDAR) or Anti-leucine-rich Glioma-inactivated 1 (LGI1) Encephalitis (Cielo) NCT05503264	Recruiting